Literature DB >> 29244529

What Is the Role of Symptom Management and Patient-Reported Outcomes in Adherence to Aromatase Inhibitors?

Gabrielle Rocque1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29244529     DOI： 10.1200/JCO.2017.76.3250

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

Authors:  Kate E Roberts; India T Adsett; Kirsty Rickett; Sophie M Conroy; Mark D Chatfield; Natasha E Woodward
Journal:  Cochrane Database Syst Rev       Date:  2022-01-10

Review 2.  Patient Navigation in Cancer: The Business Case to Support Clinical Needs.

Authors:  Ronald M Kline; Gabrielle B Rocque; Elizabeth A Rohan; Kris A Blackley; Cynthia A Cantril; Mandi L Pratt-Chapman; Howard A Burris; Lawrence N Shulman
Journal:  J Oncol Pract       Date:  2019-09-11       Impact factor: 3.840

Review 3.  Aromatase Inhibitors-Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects.

Authors:  Sara Tenti; Pierpaolo Correale; Sara Cheleschi; Antonella Fioravanti; Luigi Pirtoli
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.